Charles M. Baum - Dec 29, 2023 Form 4 Insider Report for Mirati Therapeutics, Inc. (MRTX)

Role
Interim CEO, Director
Signature
/s/ John Moriarty, Attorney-in-Fact
Stock symbol
MRTX
Transactions as of
Dec 29, 2023
Transactions value $
$1,199,969
Form type
4
Date filed
1/3/2024, 05:52 PM
Previous filing
Aug 10, 2023
Next filing
Jan 23, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRTX Common Stock Award $1.2M +20.4K +8.99% $58.75 248K Dec 29, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 (1) Grant of Restricted Stock Units (RSUs). Shares will vest 25% annually on the anniversary of the grant date until fully vested.